Sponsored
Global Implantable Medical Devices Market



Global Implantable Medical Devices Market Insights
The Global Implantable Medical Devices Market Size was valued at USD 98.45 Billion in 2021, and it is expected to reach a value of USD 157.07 Billion by 2028, at a CAGR of 6.90% over the forecast period (2022 - 2028).
Devices that are implanted inside or on the surface of the body are known as implantable medical devices. Many implants are prostheses or artificial body components that are meant to replace missing bodily parts. Other implants help organs and tissues by delivering medication, monitoring biological functioning, or providing assistance. The implants can be left in place indefinitely for diagnostic, monitoring, or therapeutic purposes, or they can be taken out when no longer required.
Know more about : https://skyquestt.com/report/implantable-medical-devices-market

Global Implantable Medical Devices Market Segmental Analysis
The Global Implantable Medical Devices Market is segmented on the basis of type, product, nature of device, end-use, and region. Based on the type, the market is segmented into diagnostic and treatment. Based on the product, the market is segmented into cardiovascular, ophthalmology, orthopedic, plastic surgery, dental, and neurology. The cardiovascular segment further includes implantable cardiac defibrillators [ICDs], stents, pacemakers, implantable cardiac monitors (ICM), ventricular assist devices, and cardiac resynchronization therapy devices (CRT). The ophthalmology segment includes intraocular lenses and glaucoma implants. The orthopedic segment includes joint reconstruction, spinal devices, and trauma fixation devices.

Top Player’s Company Profiles
• Abbott Laboratories (US)
• Boston Scientific Corporation (US)
• C. R. Bard, Inc. (US)
• Globus Medical Inc. (US)
• Institut Straumann AG (Switzerland)
• Integra Lifesciences Holdings Corporation (US)
• Johnson & Johnson Inc. (US)
• LivaNova PLC (UK)
• MED-EL (Austria)
• Medtronic plc (Ireland)
• Nurotron Biotechnology Co., Ltd. (China)
• Nuvasive Inc. (US)
• Smith & Nephew Plc (US)
• Sonova Holding AG (Switzerland)
• St. Jude Medical Inc. (US)
• Stryker Corporation (US)
• William Demant Holding A/S (Denmark)
• Wright Medical Group N.V. (US)
Get free sample pdf report copy at : https://skyquestt.com/sample-request/implantable-medical-devices-market

Recent Developments
• In February 2022, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company's CardioMEMS HF System to support the care of more people living with heart failure.
• In February 2022, Boston Scientific Corporation announced the completion of its purchase of Baylis Medical Company Inc., a provider of innovative transseptal access solutions as well as guidewires, sheaths, and dilators used in catheter-based left-heart surgeries.
• In January 2022, J&J Medical Devices Companies announced that it will work with Microsoft to better allow and grow J&JMDC's secure and compliant digital surgery environment. The Microsoft Cloud will assist JJMDC in realizing its mission of advancing skills, improving workflow, and improving surgical decision making for a better overall customer experience and greater patient and economic outcomes.

Global Implantable Medical Devices Market Global Implantable Medical Devices Market Insights The Global Implantable Medical Devices Market Size was valued at USD 98.45 Billion in 2021, and it is expected to reach a value of USD 157.07 Billion by 2028, at a CAGR of 6.90% over the forecast period (2022 - 2028). Devices that are implanted inside or on the surface of the body are known as implantable medical devices. Many implants are prostheses or artificial body components that are meant to replace missing bodily parts. Other implants help organs and tissues by delivering medication, monitoring biological functioning, or providing assistance. The implants can be left in place indefinitely for diagnostic, monitoring, or therapeutic purposes, or they can be taken out when no longer required. Know more about : https://skyquestt.com/report/implantable-medical-devices-market Global Implantable Medical Devices Market Segmental Analysis The Global Implantable Medical Devices Market is segmented on the basis of type, product, nature of device, end-use, and region. Based on the type, the market is segmented into diagnostic and treatment. Based on the product, the market is segmented into cardiovascular, ophthalmology, orthopedic, plastic surgery, dental, and neurology. The cardiovascular segment further includes implantable cardiac defibrillators [ICDs], stents, pacemakers, implantable cardiac monitors (ICM), ventricular assist devices, and cardiac resynchronization therapy devices (CRT). The ophthalmology segment includes intraocular lenses and glaucoma implants. The orthopedic segment includes joint reconstruction, spinal devices, and trauma fixation devices. Top Player’s Company Profiles • Abbott Laboratories (US) • Boston Scientific Corporation (US) • C. R. Bard, Inc. (US) • Globus Medical Inc. (US) • Institut Straumann AG (Switzerland) • Integra Lifesciences Holdings Corporation (US) • Johnson & Johnson Inc. (US) • LivaNova PLC (UK) • MED-EL (Austria) • Medtronic plc (Ireland) • Nurotron Biotechnology Co., Ltd. (China) • Nuvasive Inc. (US) • Smith & Nephew Plc (US) • Sonova Holding AG (Switzerland) • St. Jude Medical Inc. (US) • Stryker Corporation (US) • William Demant Holding A/S (Denmark) • Wright Medical Group N.V. (US) Get free sample pdf report copy at : https://skyquestt.com/sample-request/implantable-medical-devices-market Recent Developments • In February 2022, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company's CardioMEMS HF System to support the care of more people living with heart failure. • In February 2022, Boston Scientific Corporation announced the completion of its purchase of Baylis Medical Company Inc., a provider of innovative transseptal access solutions as well as guidewires, sheaths, and dilators used in catheter-based left-heart surgeries. • In January 2022, J&J Medical Devices Companies announced that it will work with Microsoft to better allow and grow J&JMDC's secure and compliant digital surgery environment. The Microsoft Cloud will assist JJMDC in realizing its mission of advancing skills, improving workflow, and improving surgical decision making for a better overall customer experience and greater patient and economic outcomes.
0 Comments 0 Shares
Sponsored

Instant Money Transfers - Open Free Account

Mobile Money made easy, all currencies

Sponsored